Research Article | | Peer-Reviewed

Construction of a Cuproptosis-Related Gene Clinical Prediction Model for Juvenile Idiopathic Arthritis Using Machine Learning

Received: 23 November 2023    Accepted: 7 December 2023    Published: 22 December 2023
Views:       Downloads:
Abstract

Objective: Juvenile Idiopathic Arthritis (JIA) is a chronic inflammatory joint disease affecting children and adolescents, where early diagnosis and treatment are crucial for improving prognosis. This study aimed to identify cuproptosis-related genes in JIA and develop a clinical predictive model. Methods: The GSE13849 dataset was retrieved from the GEO database to extract cuproptosis-related genes. Key JIA genes were selected using the Boruta and SVM-REF algorithms, followed by the construction of a clinical prediction model. The model's predictive capacity was validated using the concordance index (C-index), Receiver Operating Characteristic (ROC) curves, and calibration curves. Patient net benefit was evaluated through clinical decision curves, with internal validation conducted via Bootstrap. Results: The Boruta and SVM-REF algorithms identified four and five core cuproptosis-related genes, respectively, intersecting to yield three core genes (PDHA1, LIAS, DLAT). A clinical prediction model was established using multivariate logistic regression, exhibiting a C-index of 0.75 and an area under the ROC curve of 0.749. Clinical decision curve analysis demonstrated the highest net clinical benefit at a threshold probability range of 0.15 to 0.9, ensuring no harm to other patients. Internal validation reported a C-index of 0.755 and an area under the ROC curve of 0.736. Conclusion: The JIA clinical prediction model, based on three cuproptosis-related genes, demonstrates substantial predictive diagnostic capability, contributing to the early diagnosis of JIA patients.

Published in International Journal of Genetics and Genomics (Volume 11, Issue 4)
DOI 10.11648/j.ijgg.20231104.14
Page(s) 133-138
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Juvenile Idiopathic Arthritis, Cuproptosis, Machine Learning, Clinical Prediction Model, Boruta, SVM-REF

References
[1] Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004; 31(2): 390-392.
[2] Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007; 369(9563): 767-778. doi: 10.1016/S0140-6736(07)60363-8.
[3] Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011; 377(9783): 2138-2149. doi: 10.1016/S0140-6736(11)60244-4.
[4] Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014; 81(2): 112-117. doi: 10.1016/j.jbspin.2013.09.003.
[5] Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022; 375(6586): 1254-1261. doi: 10.1126/science.abf0529.
[6] Wittkowski H, Frosch M, Wulffraat N, et al. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum. 2008; 58(12): 3924-3931. doi: 10.1002/art.24137.
[7] Shimizu M, Nakagishi Y, Yachie A. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine. 2013; 61(2): 345-348. doi: 10.1016/j.cyto.2012.11.025.
[8] Park C, Miranda-Garcia M, Berendes R, et al. MRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever. Rheumatology (Oxford). 2022; 61(7): 3082-3092. doi: 10.1093/rheumatology/keab729.
[9] Rosina S, Natoli V, Santaniello S, et al. Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis. Expert Rev Clin Immunol. 2021; 17(8): 853-870. doi: 10.1080/1744666X.2021.1945441.
[10] Nziza N, Jeziorski E, Delpont M, et al. Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis. Cells. 2019; 8(12): 1521. doi: 10.3390/cells8121521.
[11] Souma K, Fujimura J, Nishiyama A, et al. Serum interleukin-18 level as a possible early diagnostic marker of systemic juvenile idiopathic arthritis. Int J Rheum Dis. 2023; 26(3): 551-553. doi: 10.1111/1756-185X.14534.
[12] Sudoł-Szopińska I, Herregods N, Doria AS, et al. Advances in Musculoskeletal Imaging in Juvenile Idiopathic Arthritis. Biomedicines. 2022; 10(10): 2417. doi: 10.3390/biomedicines10102417.
[13] Mello, A. C., Freitas, M., Coutinho, L., et al. Machine Learning Supports Long Noncoding RNAs as Expression Markers for Endometrial Carcinoma. BioMed research international, 2020, 3968279. https://doi.org/10.1155/2020/3968279.
[14] Hu Y, Guo G, Li J, et al. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis. Cancer Biomark. 2020; 27(2): 195-206. doi: 10.3233/CBM-19069.
[15] Van Nieuwenhove E, Lagou V, Van Eyck L, et al. Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes. Ann Rheum Dis. 2019 May; 78(5): 617-628. doi: 10.1136/annrheumdis-2018-214354.
[16] Mo X, Chen X, Ieong C, et al Early Prediction of Clinical Response to Etanercept Treatment in Juvenile Idiopathic Arthritis Using Machine Learning. Front Pharmacol. 2020 Jul 31; 11: 1164. doi: 10.3389/fphar.2020.01164.
[17] Baker ZN, Cobine PA, Leary SC. The mitochondrion: a central architect of copper homeostasis. Metallomics. 2017; 9(11): 1501-1512. doi: 10.1039/c7mt00221a.
[18] Shi J, Cai C. Research Progress on the Mechanism of Itaconate Regulating Macrophage Immunometabolism. Front Immunol. 2022; 13: 937247. Published 2022 Jun 23. doi: 10.3389/fimmu.2022.937247.
[19] Nakkala JR, Yao Y, Zhai Z, et al. Dimethyl Itaconate-Loaded Nanofibers Rewrite Macrophage Polarization, Reduce Inflammation, and Enhance Repair of Myocardic Infarction. Small. 2021; 17(17): e2006992. doi: 10.1002/smll.202006992.
[20] Lin J, Ren J, Gao DS, et al. The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities. Front Chem. 2021; 9: 669308. doi: 10.3389/fchem.2021.669308.
[21] Ji DY, Park SH, Park SJ, et al. Comparative assessment of Graves' disease and main extrathyroidal manifestation, Graves' ophthalmopathy, by non-targeted metabolite profiling of blood and orbital tissue. Sci Rep. 2018; 8(1): 9262. doi: 10.1038/s41598-018-27600-0.
[22] Ran XM, Xiao H, Tang YX, et al. The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation. Sci Rep. 2023; 13(1): 19474. doi: 10.1038/s41598-023-45076-5.
[23] Zhang P, Zhao JH, Yuan LX, et al. DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases. Sci Rep. 2023; 13(1): 17295. doi: 10.1038/s41598-023-43835-y.
[24] Yi X, Kim K, Yuan W, et al. Mice with heterozygous deficiency of lipoic acid synthase have an increased sensitivity to lipopolysaccharide-induced tissue injury. J Leukoc Biol. 2009; 85(1): 146-153. doi: 10.1189/jlb.0308161.
Cite This Article
  • APA Style

    Hong, Y., Cai, X., Chen, X., Huang, X., Yan, Z., et al. (2023). Construction of a Cuproptosis-Related Gene Clinical Prediction Model for Juvenile Idiopathic Arthritis Using Machine Learning. International Journal of Genetics and Genomics, 11(4), 133-138. https://doi.org/10.11648/j.ijgg.20231104.14

    Copy | Download

    ACS Style

    Hong, Y.; Cai, X.; Chen, X.; Huang, X.; Yan, Z., et al. Construction of a Cuproptosis-Related Gene Clinical Prediction Model for Juvenile Idiopathic Arthritis Using Machine Learning. Int. J. Genet. Genomics 2023, 11(4), 133-138. doi: 10.11648/j.ijgg.20231104.14

    Copy | Download

    AMA Style

    Hong Y, Cai X, Chen X, Huang X, Yan Z, et al. Construction of a Cuproptosis-Related Gene Clinical Prediction Model for Juvenile Idiopathic Arthritis Using Machine Learning. Int J Genet Genomics. 2023;11(4):133-138. doi: 10.11648/j.ijgg.20231104.14

    Copy | Download

  • @article{10.11648/j.ijgg.20231104.14,
      author = {Yiwei Hong and Xu Cai and Xinpeng Chen and Xinmin Huang and Zhengbo Yan and Peihu Li and Jianwei Xiao},
      title = {Construction of a Cuproptosis-Related Gene Clinical Prediction Model for Juvenile Idiopathic Arthritis Using Machine Learning},
      journal = {International Journal of Genetics and Genomics},
      volume = {11},
      number = {4},
      pages = {133-138},
      doi = {10.11648/j.ijgg.20231104.14},
      url = {https://doi.org/10.11648/j.ijgg.20231104.14},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijgg.20231104.14},
      abstract = {Objective: Juvenile Idiopathic Arthritis (JIA) is a chronic inflammatory joint disease affecting children and adolescents, where early diagnosis and treatment are crucial for improving prognosis. This study aimed to identify cuproptosis-related genes in JIA and develop a clinical predictive model. Methods: The GSE13849 dataset was retrieved from the GEO database to extract cuproptosis-related genes. Key JIA genes were selected using the Boruta and SVM-REF algorithms, followed by the construction of a clinical prediction model. The model's predictive capacity was validated using the concordance index (C-index), Receiver Operating Characteristic (ROC) curves, and calibration curves. Patient net benefit was evaluated through clinical decision curves, with internal validation conducted via Bootstrap. Results: The Boruta and SVM-REF algorithms identified four and five core cuproptosis-related genes, respectively, intersecting to yield three core genes (PDHA1, LIAS, DLAT). A clinical prediction model was established using multivariate logistic regression, exhibiting a C-index of 0.75 and an area under the ROC curve of 0.749. Clinical decision curve analysis demonstrated the highest net clinical benefit at a threshold probability range of 0.15 to 0.9, ensuring no harm to other patients. Internal validation reported a C-index of 0.755 and an area under the ROC curve of 0.736. Conclusion: The JIA clinical prediction model, based on three cuproptosis-related genes, demonstrates substantial predictive diagnostic capability, contributing to the early diagnosis of JIA patients.
    },
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Construction of a Cuproptosis-Related Gene Clinical Prediction Model for Juvenile Idiopathic Arthritis Using Machine Learning
    AU  - Yiwei Hong
    AU  - Xu Cai
    AU  - Xinpeng Chen
    AU  - Xinmin Huang
    AU  - Zhengbo Yan
    AU  - Peihu Li
    AU  - Jianwei Xiao
    Y1  - 2023/12/22
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ijgg.20231104.14
    DO  - 10.11648/j.ijgg.20231104.14
    T2  - International Journal of Genetics and Genomics
    JF  - International Journal of Genetics and Genomics
    JO  - International Journal of Genetics and Genomics
    SP  - 133
    EP  - 138
    PB  - Science Publishing Group
    SN  - 2376-7359
    UR  - https://doi.org/10.11648/j.ijgg.20231104.14
    AB  - Objective: Juvenile Idiopathic Arthritis (JIA) is a chronic inflammatory joint disease affecting children and adolescents, where early diagnosis and treatment are crucial for improving prognosis. This study aimed to identify cuproptosis-related genes in JIA and develop a clinical predictive model. Methods: The GSE13849 dataset was retrieved from the GEO database to extract cuproptosis-related genes. Key JIA genes were selected using the Boruta and SVM-REF algorithms, followed by the construction of a clinical prediction model. The model's predictive capacity was validated using the concordance index (C-index), Receiver Operating Characteristic (ROC) curves, and calibration curves. Patient net benefit was evaluated through clinical decision curves, with internal validation conducted via Bootstrap. Results: The Boruta and SVM-REF algorithms identified four and five core cuproptosis-related genes, respectively, intersecting to yield three core genes (PDHA1, LIAS, DLAT). A clinical prediction model was established using multivariate logistic regression, exhibiting a C-index of 0.75 and an area under the ROC curve of 0.749. Clinical decision curve analysis demonstrated the highest net clinical benefit at a threshold probability range of 0.15 to 0.9, ensuring no harm to other patients. Internal validation reported a C-index of 0.755 and an area under the ROC curve of 0.736. Conclusion: The JIA clinical prediction model, based on three cuproptosis-related genes, demonstrates substantial predictive diagnostic capability, contributing to the early diagnosis of JIA patients.
    
    VL  - 11
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China

  • Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China

  • Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China

  • Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China

  • Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China

  • Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China

  • Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, China

  • Sections